Themipyrrnom 0.2mg Injection
Marketer
Themis Medicare Ltd
Salt Composition
Glycopyrrolate (0.2mg)
Overview Themipyrrnom 0.2mg Injection
An injection of 0.2mg Themipyrrnom, an anticholinergic agent, is administered before, during, or after surgery to minimize bodily secretions and counteract the side effects of certain surgical anesthetics (such as muscle relaxants). This medication also aids in peptic ulcer treatment when oral administration is impractical. Administered by a healthcare professional, Themipyrrnom requires full disclosure of all other medications to your physician due to potential interactions. Continue treatment as directed; premature discontinuation may lead to symptom recurrence and condition exacerbation. Common adverse reactions include xerostomia, urinary retention, blurred vision, photosensitivity, mydriasis, cycloplegia, tachycardia, bradycardia, palpitations, elevated intraocular pressure, and decreased perspiration. Alcohol consumption should be avoided due to potential additive sedative effects. Disclose any pre-existing glaucoma, myasthenia gravis, congestive heart failure, or hypertension to your doctor before using this medication.
Uses of Themipyrrnom 0.2mg Injection
Total Anesthesia | Gastric Ulceration
Major Benefits of Themipyrrnom 0.2mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Themipyrrnom 0.2mg Injection:
- Urinary retention
- Blurred vision
- Dilatation of pupil
- Cycloplegia (paralysis of the ciliary muscle of the eye)
- Ocular hyperemia
- Slow heart rate
- Palpitations
- Reduced sweating
- Increased heart rate
- Increased intraocular pressure
How to use Themipyrrnom 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Themipyrrnom 0.2mg Injection works:
Themipyrrnom 0.2mg Injection is an anticholinergic agent that inhibits the action of acetylcholine, a neurotransmitter, within the central nervous system.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Themipyrrnom 0.2mg Injection may pose safety risks; seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The administration of 0.2mg Themipyrrnom Injection is typically deemed safe for pregnant individuals. Preclinical trials using animal models have revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Themipyrrnom 0.2mg Injection during lactation is likely safe. Available human data indicate minimal infant risk. However, prolonged use of Themipyrrnom 0.2mg Injection may decrease breast milk supply.
DrivingUNSAFE
Administering Themipyrrnom 0.2mg Injection might induce adverse reactions impacting driving capabilities. Vision and coordination may be compromised by Themipyrrnom 0.2mg Injection, potentially impairing driving skills.
KidneyCAUTION
Patients with impaired kidney function require careful monitoring when receiving Themipyrrnom 0.2mg Injection; dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Themipyrrnom 0.2mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Themipyrrnom 0.2mg Injection :
NA
Facts to Know About Themipyrrnom 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Type | Quaternary Ammonium Compounds |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Anesthesia and Anticholinergic Drugs |
3,018 People bought this recently